Wharton Jelly Mesenchymal Stromal Cells as GVHD Prophylaxis

Clinical trial NCT05855707 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05855707
Sponsor: Central Hospital, Nancy, France
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Allogeneic Disease GVHD,Acute Graft Failure

Start date: 2023-09-01
Primary completion: 2025-09-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.